CRISPR-Cas9 is a genome editing method that uses a Cas9 enzyme to precisely cut DNA at a targeted location guided by a short RNA molecule. It works by integrating fragments of viral DNA into the host's genome to develop immunity. When the same virus later infects the host, CRISPR-Cas9 can recognize and cut the viral DNA. The method involves designing an RNA guide sequence to target a specific gene, with the Cas9 enzyme cutting the DNA 3-4 bases before a protospacer adjacent motif sequence. Potential applications of CRISPR-Cas9 genome editing include correcting genetic defects and developing therapies.